Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Roche Wants Novartis Units’ Launch of Esbriet Copies Blocked

April 1, 2022, 9:29 PM

Two Roche Holding AG units asked a federal judge in Delaware to block two Novartis AG units from selling a generic version of Esbriet while he considers their emergency request for a temporary restraining order and until Roche’s appeal of his ruling that the copycats don’t infringe six patents is resolved.

Judge Richard G. Andrews, who held a bench trial in November, ruled on March 22 that a generic version of Esbriet proposed by NovartisSandoz Inc. and Lek Pharmaceuticals units doesn’t infringe six patents for the drug. Esbriet is a treatment for an irreversible lung disease that ...